Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients
Completed
- Conditions
- Coronavirus Infection
- Registration Number
- NCT04325048
- Lead Sponsor
- Cordio Medical
- Brief Summary
Study on adult patients positive to COVID-19 virus. After signing informed consent and undergoing screening assessments, eligible patients will record few times a day several pre-defined sentences to the Cordio App installed in a smartphone/tablet.
The app will upload the vocal data to the sponsor's servers for analysis. The patient will record at hospital admittance (COVID-19 positive) until patient defined as COVID-19 negative and free of relevant clinical symptoms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
- 18+ years old
- Diagnosed with COVID-19 positive patients according to medical center guidelines, with symptoms of cough and or dyspnea. Patients that diagnosed with pneumonia, should be confirmed by X-ray and/or CT.
- Able to understand and provide written informed consent (manually or electronically or giving their consent via the telephone to the study investigator in case of isolated patients).
Exclusion Criteria
- Subjects, in the Investigator's opinion, unable to comply with the daily use of the application including mental disorders (e.g., depression, dementia).
- Patients with severe alcohol or drug use.
- Women who are pregnant or lactating.
- Participating in another investigation therapy that may interfere with study results (according to investigator discretion)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Voice anaysis 1-2 years patient voice that is recorded during the study will be anylaysis with specific algorithms
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rambam Medical Center
🇮🇱Haifa, Israel